A Stage-Phased Psychodynamic Intervention For School Refusal In Adolescent Bipolar Disorder

Summary

This report demonstrates a three-phase psychodynamic intervention for adolescent bipolar disorder. It aims to treat severe school refusal by resolving family triangulation and separation conflicts, providing a structured roadmap for achieving functional recovery and school reintegration beyond pharmacological stabilization.

Abstract

Adolescent bipolar disorder is a severe psychiatric condition frequently complicated by school refusal behavior, a debilitating functional impairment that often persists even after the pharmacological stabilization of mood symptoms. While medication effectively targets biological dysregulation, it frequently fails to resolve the deep-seated separation-individuation conflicts and pathological family dynamics, such as triangulation, that actively maintain social withdrawal. Given the scarcity of manualized psychotherapeutic protocols for this specific clinical challenge, this article demonstrates a structured, stage-phased psychodynamic psychotherapy protocol for the treatment of adolescent bipolar disorder comorbid with severe school refusal behavior. We present a comprehensive 60-session intervention applied to a 17-year-old female patient. The protocol integrates standard pharmacotherapy with a three-phase psychodynamic model: (1) Alliance and stabilization; (2) Working through, utilizing dream analysis and transference interpretation; and (3) Termination and separation. Progress was monitored via serial electroencephalogram (EEG) topography and standardized psychological scales. Application of this protocol was associated with the resolution of school refusal and successful university entry in this patient. Longitudinal assessment demonstrated a significant reduction in depression scores to within normal ranges, although anxiety scores remained above the clinical threshold at follow-up. Furthermore, while EEG topography demonstrated overall stability, mild -band dysregulation persisted. This protocol provides a step-by-step roadmap for clinicians, highlighting that resolving underlying family triangulation may be a valuable component in supporting successful school reintegration in pediatric bipolar disorder.

Introduction

Pediatric Bipolar Disorder (PBD) constitutes a severe, chronic psychiatric condition associated with profound psychosocial impairment and a disproportionate burden on healthcare systems. Contemporary epidemiological data suggest that PBD is far more prevalent than historically recognized, affecting approximately 1% to 3% of the global youth population¹. Unlike adult-onset bipolar disorder, the early-onset phenotype is frequently characterized by a rapid-cycling or mixed-episode course, higher rates of psychiatric comorbidity, and a greater resistance to standard pharmacological interventions². Longitudinal observations, such as those from the Course and Outcome of Bipolar Youth (COBY) study, underscore the malignant trajectory of the disorder; adolescents with PBD spend a substantial proportion of their formative years symptomatic, particularly in depressive or mixed states, which severely disrupts developmental milestones³.

Despite the escalating prevalence, the clinical identification of PBD remains fraught with complexity. Recent meta-analytic evidence has consistently highlighted a critical "diagnostic latency" period, demonstrating that patients often endure a delay of several years between symptom onset and accurate clinical management⁴. This interval represents a window of lost opportunity, during which adolescents are frequently misdiagnosed with major depressive disorder (MDD) or attention-deficit/hyperactivity disorder (ADHD). Such misclassification not only delays appropriate mood-stabilizing treatment but may also precipitate iatrogenic destabilization through the unopposed use of antidepressants or stimulants, thereby accelerating the kindling process of the disease^2,4.

One of the most debilitating functional consequences of untreated or partially treated PBD is school refusal behavior (SRB). Distinct from truancy, which implies a covert conduct problem without emotional distress, SRB is defined by a child's refusal to attend school driven by overwhelming emotional discomfort, including severe anxiety, somatic complaints, and depressive withdrawal^5,6. Kearney's seminal conceptualization of SRB emphasizes its heterogeneity, identifying it as a final common pathway for various forms of emotional dysregulation⁶. In the context of PBD, SRB is not merely a behavioral infraction but a sentinel sign of acute psychopathology. Community-based studies demonstrated that children with SRB exhibit significantly elevated rates of mood and anxiety disorders compared to non-refusing peers⁷. The mechanism linking PBD to SRB is multifaceted. Evidence suggests that anxiety symptoms, often comorbid with or intrinsic to bipolar mixed states, are potent predictors of poor school attendance⁸. Furthermore, the cognitive sequelae of PBD, including deficits in executive function and sustained attention, persist even during euthymic periods, rendering the academic environment cognitively overwhelming for these students⁹. The long-term ramifications of this educational disengagement are severe; without effective intervention, SRB crystallizes into chronic social withdrawal, leading to academic failure and long-term socioeconomic marginalization¹⁰. This profound functional collapse severely impacts a young person's overall quality of life (QoL), a facet of impairment as debilitating as that seen in other severe chronic illnesses. Highlighting this QoL burden is critical for understanding the urgency of developing effective psychosocial interventions¹¹.

The urgency of effective intervention is further amplified by the high lethality associated with PBD. A history of suicide attempts serves as a robust predictor of poor prognosis in pediatric bipolar patients, with the risk being exacerbated during mixed episodes where high energy coincides with dysphoric mood¹². This risk is inextricably linked to the patient's family environment. Empirical evidence demonstrates that family dysfunction, characterized by high conflict and low cohesion, serves as a primary environmental moderator of the illness course¹³. In many cases, the adolescent's symptoms are maintained by a pathological family homeostasis, necessitating interventions that transcend the individual patient.

Current international treatment guidelines, including the Canadian Network for Mood and Anxiety Treatments (CANMAT)/International Society for Bipolar Disorders (ISBD) guidelines and the Indian Association of Psychiatry guidelines for children, prioritize pharmacotherapy as the cornerstone of management^14,15. Mood stabilizers and second-generation antipsychotics are established as first-line agents for acute stabilization^2,14,15. However, while these agents are effective in dampening the amplitude of mood swings, their capacity to restore functional recovery is limited. Evidence reveals a significant discrepancy between symptom reduction and functional restoration; many adolescents achieve euthymia yet remain functionally impaired, particularly regarding school reintegration and social competence¹⁶. This "functional gap" suggests that biological stabilization is a necessary but insufficient condition for recovery in complex PBD cases^2,17.

To bridge this gap, adjunctive psychosocial interventions are increasingly recommended. Randomized trials have firmly established the efficacy of family-focused therapy (FFT) and cognitive behavioral therapy (CBT) in reducing recurrence rates and stabilizing symptoms among high-risk youth^17,18. These interventions typically emphasize psychoeducation and communication skills training. However, for a subset of treatment-resistant adolescents, particularly those with severe SRB, these psychoeducational and skill-based approaches may not be sufficient. A psychodynamic approach becomes clinically necessary when school refusal is driven not merely by a behavioral deficit or lack of coping skills, but by entrenched, severe family conflicts. In many complex cases, the adolescent's inability to attend school is deeply entangled with pathological family "triangulation." In this dynamic, the patient's illness inadvertently becomes the focal point that distracts from or mediates parental distress^19,20. Consequently, the adolescent becomes developmentally 'stuck,' unable to achieve normal autonomy (separation-individuation) because their continued dependency stabilizes the family unit. When such profound interpersonal barriers and emotional defenses block recovery, patients are often unable to engage with standard CBT. Addressing this requires a therapeutic modality that moves beyond conscious symptom management to directly target and restructure the family relationship patterns actively maintaining the social withdrawal.

Despite the clinical necessity of addressing these complex dynamics in PBD patients, there is a paucity of structured, reproducible protocols in the literature. Recent reviews note that while psychoanalytic therapies show promise, the evidence base is fragmented by a lack of manualized approaches suitable for acute clinical settings²¹. Addressing this unmet need, this study delineates a stage-phased psychodynamic psychotherapy protocol specifically designed for adolescent bipolar disorder comorbid with school refusal. Grounded in the integration of pharmacological stabilization and depth psychology, this protocol operationalizes a three-phase model: (1) Alliance and stabilization, (2) Trauma processing and working through, and (3) Termination and separation. By presenting a detailed procedural framework alongside a representative case analysis, this article illustrates how targeting deep-seated defense mechanisms and family object relations may facilitate functional recovery and school reintegration in cases where conventional management has failed.

Case Presentation:

A 17-year-old female was admitted to the outpatient mental health department in March 2021 with a significant history of emotional instability and acute school refusal. Symptoms initially emerged in 2016 as non-suicidal self-injury (NSSI), specifically wrist-cutting, occurring intermittently during periods of stress. Before admission, the patient had been a high-achieving student, ranking first in her grade. However, in the second semester of her sophomore year, triggered by the unexpected death of her maternal grandmother, who had served as a primary attachment figure, she began experiencing unprovoked crying spells, profound loneliness, and severe insomnia. She reported explicit suicidal ideation, including specific plans to jump from a building, drown, or overdose on medication. Efforts by family members and school personnel to manage her condition were ineffective, as the patient felt misunderstood by her parents and feared peer judgment, resulting in complete avoidance of the school environment. Despite her prior academic success, depressive symptoms progressively worsened in the weeks leading up to admission, marked by the "concretization" of conflicting internal voices debating whether to continue living. The patient had no notable past medical history of organic brain disease. Family history revealed complex interpersonal dynamics: the father was emotionally distant, while the mother, who was 12 years younger than the father, exhibited marked emotional instability.

On physical examination, the patient appeared physically small and avoided eye contact by pulling her cap low. She was alert but guarded. Neurological examination revealed no focal deficits. Laboratory investigations, including thyroid function tests and complete blood count, were within normal reference ranges. However, an electroencephalogram (EEG) showed a background rhythm of 9–10 Hz α activity mixed with increased θ band power (5–7 Hz), suggesting mild cortical dysfunction rather than epileptiform discharges.

Diagnosis, Assessment, and Plan:

The condition of the patient was diagnosed as bipolar disorder, current episode depressed with mixed features, comorbid with school refusal behavior and parent-child relational problem (DSM-5 V-code).

Upon admission, clinical priorities included stabilizing immediate suicide risk and developing a psychodynamic understanding of symptom formation. The diagnostic process carefully adhered to DSM-5 criteria and systematically addressed differential diagnoses. While the surface presentation initially resembled major depressive disorder (MDD), the patient's clinical picture included distinct mixed affective features (e.g., severe inner psychomotor tension, racing conflicting thoughts, and impulsive NSSI) alongside a documented retrospective history of brief hypomanic symptoms, e.g., periods of decreased need for sleep with intense goal-directed academic overactivity before the depressive crash. This, combined with a strong family history of mood lability, established the diagnosis of bipolar spectrum disorder over MDD. primary social anxiety disorder was ruled out, as her fear of peer judgment was secondary to her depressive withdrawal and profound shame rather than a primary fear of social scrutiny. Furthermore, while borderline personality disorder was considered, given the NSSI and affective instability, her mood episodes were sustained and autonomous rather than purely reactive to interpersonal slights.

Standardized psychometric assessments (self-rating depression scale [SDS], self-rating anxiety scale [SAS], symptom checklist-90 [SCL-90]) were utilized not as primary diagnostic tools, but to quantitatively baseline the patient's subjective distress and monitor symptom fluctuations over the treatment course. The SDS score was 57, and the SAS score was 51, both exceeding clinical thresholds and confirming the high anxiety burden driving her school refusal. A psychodynamic formulation identified a "triangulated" family structure in which the patient functioned as a buffer between an estranged father and a dominant, intrusive mother, contributing to the development of a rigid superego and repressed hostility. Given the high suicide risk and complexity of familial dynamics, a dual-modality treatment approach was clinically indicated.

Following multidisciplinary discussion and obtaining informed consent from the legal guardian, the patient was scheduled for a 60-session course of psychodynamic psychotherapy combined with pharmacotherapy. This structured protocol was selected over medication alone to address underlying personality organization and trauma-related responses driving school refusal. The treatment plan included the careful titration of sertraline and quetiapine. Sertraline was initiated to urgently target the severe depressive symptoms and crippling anxiety. Crucially, to mitigate the known risk of antidepressant-induced affective switching (manic switch) in bipolar patients, quetiapine was co-administered. A low-dose atypical antipsychotic strategy (quetiapine 25–50 mg) was specifically selected over traditional mood stabilizers (e.g., lithium or valproate) due to its dual efficacy: providing rapid rescue for her severe insomnia and acting as a mood-stabilizing "ceiling" against potential sertraline-induced activation. Concurrently, psychotherapy followed a three-phase model: Alliance building, trauma processing, and termination/separation. Post-treatment management included follow-up appointments during university breaks to monitor social adaptation.

Protocol

This protocol was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of The First People's Hospital of Lianyungang (Approval No.LW-20260325001-01). Written informed consent for treatment, as well as explicit consent to publish this case report and any accompanying non-identifiable data/figures, was obtained from the patient and her legal guardian.

1. Patient selection and pre-treatment preparation

1. A 17-year-old female was selected based on a DSM-5 diagnosis of Bipolar Disorder (current episode depressed with mixed features), comorbid with severe school refusal and a history of non-suicidal self-injury (NSSI).
2. Baseline assessment: The patient underwent comprehensive psychological testing (SDS, SAS, SCL-90) and biological screening (quantitative EEG topography) to establish baseline metrics and rule out organic brain lesions.
3. Therapeutic frame: A therapeutic contract was established, specifying a 60-session course with a frequency of once weekly (60 min per session) to create a stable and predictable "holding environment."

2. Pharmacological and biological stabilization

1. Initiation rationale: Pharmacotherapy was initiated with sertraline (50 mg/day) to target acute depressive withdrawal and quetiapine (25 mg/day at bedtime) to address insomnia and serve as a mood-stabilizing "ceiling" against potential antidepressant-induced manic switching.
2. Titration logic: Dosages were maintained for the first 4 weeks to assess tolerability. Between months 2–4 (corresponding to Phase II of psychotherapy), sertraline was titrated to 100 mg/day and quetiapine to 50 mg/day to manage refractory anxiety during trauma processing.
3. Coordination: Medication reviews were conducted bi-weekly for the first 2 months, then monthly. The psychiatrist and psychotherapist held bi-weekly coordination meetings to align pharmacological adjustments with the patient's emotional reactivity observed in sessions.

3. Psychodynamic psychotherapy procedure (60 sessions)

1. Phase I: Alliance and stabilization (Sessions 1–12)
   1. In this phase, the therapist utilized active listening and empathic attunement to establish a "holding environment", a non-judgmental space to contain the patient's overwhelming anxiety without immediate analytical interpretation.
   2. Progression to Phase II required the stabilization of acute suicidal ideation, regular session attendance, and the patient's demonstrated ability to self-regulate during distress.
2. Phase II: Working through and trauma processing (Sessions 13–49)
   1. The focus of the therapy shifted to interpreting unconscious defenses (e.g., intellectualization, denial). Dream analysis was employed by asking the patient to associate freely with dream imagery, which repeatedly revealed repressed hostility toward the maternal figure.
   2. Transference interpretation was utilized when the patient projected her fear of maternal criticism onto the therapist, allowing the therapist to highlight and gently challenge these relational patterns in real-time.
   3. Advancement to the next phase required the patient's cognitive recognition of the family "triangulation" dynamic and a demonstrated reduction in NSSI urges when facing family conflict.
3. Crisis intervention (Sessions 50–51)
   1. Following a relapse triggered by maternal instability, analytic neutrality was temporarily suspended in favor of direct supportive crisis intervention.
      NOTE: During the session, it was revealed that the patient had impulsively ingested an entire blister pack of quetiapine (approximately 14 tablets, 25 mg each; totaling 350 mg) at home. She did not actively disclose this ingestion to her family at the time and slept through the profound sedative effects without emergency medical intervention. Upon psychiatric evaluation in the clinic, she was fully alert and medically stable. Although inpatient psychiatric hospitalization was strongly recommended, both the patient and her family categorically refused admission. Given her stable vital signs, the treatment team agreed to continue intensive outpatient management. The therapist coordinated with the psychiatrist to establish a strict 24-hour safety contract, requiring the family to securely lock away all medications. The therapist then facilitated a reparative dialogue between the patient and mother, validating the patient's fear of abandonment.
4. Phase III: Separation and termination (Sessions 52–60)
   1. Therapy was centered on the adolescent "separation-individuation" process, catalyzed by the upcoming college entrance examination. Future visualization involved guided imagery exercises where the patient verbally navigated hypothetical university scenarios (e.g., managing dorm life, peer conflict) to build ego strength and autonomy.
   2. Successful completion of the protocol was defined by the patient's completion of the Gaokao exam and her verbalized readiness to manage emotional distress independently.

4. Outcome assessment

1. Psychometric evaluation: The SDS and SAS scales were administered by an independent clinical psychometrician at regular intervals—baseline, month 1, month 3, pre-exam, and post-exam, to objectively quantify symptom reduction without therapeutic bias.
2. Functional assessment: Social functioning was objectively evaluated by tracking school attendance records (progressing from complete absenteeism to graded re-entry, and finally full attendance) and successful participation in the National College Entrance Examination.

5. Post-treatment follow-up

1. Psychotherapy concluded at session 60 upon the patient's departure for university, while pharmacological treatment was maintained.
2. First academic break (Session 61): A structured follow-up session was conducted during the winter break. Assessment focused on environmental adaptation, specifically evaluating dormitory integration, academic performance, medication adherence, and the absence of NSSI.
3. Follow-up (6 months): Long-term prognosis was evaluated via a comprehensive psychiatric interview to monitor for affective recurrence (manic or depressive relapse), review ongoing pharmacotherapy requirements, and objectively confirm sustained academic and social functioning.

Results

The psychodynamic intervention protocol was completed in its entirety over 18 months, despite the high-risk nature of the case. Baseline demographic and clinical characteristics are summarized in Table 1. Crucially, longitudinal tracking of psychological assessment scores suggested a temporal association between therapeutic phases and symptom improvement (Figure 1).

The patient's SDS score decreased from a baseline of 57 (indicating moderate-to-se...

Discussion

The present case study suggests the potential clinical utility and feasibility of a structured, stage-phased psychodynamic psychotherapy protocol in the treatment of adolescent Bipolar Disorder (BD) comorbid with severe School Refusal Behavior (SRB). While current guidelines prioritize pharmacotherapy for symptom stabilization^14,15, the observations suggest that for the specific functional impairment of school refusal, biological remission may be a necessary but ...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Neurofax EEG-1200	Nihon Kohden		Digital EEG Topography System
Quetiapine Fumarate	AstraZeneca	NDC 0310-0275
R Software (version 4.2.0)	R Foundation for Statistical Computing	CRAN Repository
Self-Rating Anxiety Scale (SAS)	W.W.K. Zung (Developer)	Standardized 20-item Scale
Self-Rating Depression Scale (SDS)	W.W.K. Zung (Developer)	Standardized 20-item Scale
Sertraline Hydrochloride	Pfizer	NDC 0049-4900
Symptom Checklist-90 (SCL-90)	L.R. Derogatis (Developer)	SCL-90-R Standard Version